tetano
Editor, Senior Moderator
Front Immunol. 2017 Aug 31;8:1070. doi: 10.3389/fimmu.2017.01070. eCollection 2017.
[h=1]Comparison of the Protective Efficacy of Neutralizing Epitopes of 2009 Pandemic H1N1 Influenza Hemagglutinin.[/h] Peng B[SUP]1[/SUP], Peng N[SUP]1[/SUP], Zhang Y[SUP]1[/SUP], Zhang F[SUP]1[/SUP], Li X[SUP]2[/SUP], Chang H[SUP]1[/SUP], Fang F[SUP]1[/SUP], Wang F[SUP]3[/SUP], Lu F[SUP]4[/SUP], Chen Z[SUP]1,[/SUP][SUP]5[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] The 2009 H1N1 influenza (Pdm09) pandemic has been referred to as the first influenza pandemic of the twenty-first century. There is a marked difference in antigenicity between the pandemic H1N1 virus and past seasonal H1N1 viruses, which allowed the pandemic virus to spread rapidly in humans. Antibodies (Abs) against hemagglutinin (HA), especially neutralizing Abs against epitopes in the head of HA, play critical roles in defending the host against the virus. Some preexisting neutralizing Abs that recognize neutralizing epitopes of Pdm09 HA, thereby affording cross-protection, have been reported. To better understand the protective effects of epitopes in Pdm09 HA, we constructed a series of plasmid DNAs (DNA vaccines) by cloning various combinations of Pdm09 neutralizing epitopes into the HA backbone derived from A/PR/8/1934 (H1N1). We subsequently compared the protective immune responses induced by these various forms of HA in a mouse model. We found that the plasmid DNAs with epitope substitutions provided better protection against lethal virus challenge and induced higher strain-specific antibody titers, with epitope Sa being the most effective. Moreover, the combination of epitopes Sa and Sb provided almost complete protection in mice. These findings provide new insights into the protective efficacy of neutralizing epitopes of influenza HA.
[h=4]KEYWORDS:[/h] 2009 pandemic H1N1 influenza; epitope; hemagglutinin; plasmid DNA; protective efficacy
PMID: 28912784 PMCID: PMC5583165 DOI: 10.3389/fimmu.2017.01070
[h=1]Comparison of the Protective Efficacy of Neutralizing Epitopes of 2009 Pandemic H1N1 Influenza Hemagglutinin.[/h] Peng B[SUP]1[/SUP], Peng N[SUP]1[/SUP], Zhang Y[SUP]1[/SUP], Zhang F[SUP]1[/SUP], Li X[SUP]2[/SUP], Chang H[SUP]1[/SUP], Fang F[SUP]1[/SUP], Wang F[SUP]3[/SUP], Lu F[SUP]4[/SUP], Chen Z[SUP]1,[/SUP][SUP]5[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] The 2009 H1N1 influenza (Pdm09) pandemic has been referred to as the first influenza pandemic of the twenty-first century. There is a marked difference in antigenicity between the pandemic H1N1 virus and past seasonal H1N1 viruses, which allowed the pandemic virus to spread rapidly in humans. Antibodies (Abs) against hemagglutinin (HA), especially neutralizing Abs against epitopes in the head of HA, play critical roles in defending the host against the virus. Some preexisting neutralizing Abs that recognize neutralizing epitopes of Pdm09 HA, thereby affording cross-protection, have been reported. To better understand the protective effects of epitopes in Pdm09 HA, we constructed a series of plasmid DNAs (DNA vaccines) by cloning various combinations of Pdm09 neutralizing epitopes into the HA backbone derived from A/PR/8/1934 (H1N1). We subsequently compared the protective immune responses induced by these various forms of HA in a mouse model. We found that the plasmid DNAs with epitope substitutions provided better protection against lethal virus challenge and induced higher strain-specific antibody titers, with epitope Sa being the most effective. Moreover, the combination of epitopes Sa and Sb provided almost complete protection in mice. These findings provide new insights into the protective efficacy of neutralizing epitopes of influenza HA.
[h=4]KEYWORDS:[/h] 2009 pandemic H1N1 influenza; epitope; hemagglutinin; plasmid DNA; protective efficacy
PMID: 28912784 PMCID: PMC5583165 DOI: 10.3389/fimmu.2017.01070